Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | GAA | P10253 | 1/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.68 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | ACHE | P22303 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | CYP2A13 | Q16696 | 5/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.54 |
| ▸ | DRD2 | P14416 | 1/20 | 0.54 |
| ▸ | DRD4 | P21917 | 1/20 | 0.54 |
| ▸ | DRD3 | P35462 | 1/20 | 0.54 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31392633 | 0.84 | ACHE (0.68) | ALDH1A1KDM4EKMT2AMAPTGAA | |
| SCHEMBL3921135 | 0.84 | ACHE (0.68) | ALDH1A1KDM4EKMT2AMAPTLMNA | |
| SCHEMBL11193326 | 0.83 | CYP2A13 (0.75) | ALDH1A1KDM4EKMT2AMAPTLMNA | |
| SCHEMBL807336 | 0.82 | ACHE (0.66) | ALDH1A1KDM4EMAPTLMNAGAA | |
| SCHEMBL11887347 | 0.82 | ACHE (0.66) | ALDH1A1KDM4EKMT2AMAPTGAA | |
| SCHEMBL31010166 | 0.82 | ACHE (0.66) | ALDH1A1KDM4EMAPTLMNAGAA | |
| SCHEMBL5307965 | 0.81 | KDM4E (1.00) | ALDH1A1KDM4EKMT2AMAPTLMNA | |
| Hydrochloric Acid SCHEMBL16825180 | 0.81 | ACHE (0.64) | ALDH1A1KDM4EMAPTLMNAGAA | |
| SCHEMBL28573071 | 0.80 | ALDH1A1 (0.54) | ALDH1A1KDM4EKMT2AMAPTLMNA | |
| SCHEMBL21749173 | 0.80 | KDM4E (0.59) | ALDH1A1KDM4EKMT2AMAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106377150-A | Intelligent curtain control system based on technology of Internet of things and operation method thereof | 江苏建筑职业技术学院 | 2017-02-08 | — | — | CN | claimed |
| US-10982337-B2 | Corrosion inhibition | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2021-04-20 | — | — | US | disclosed |
| US-10982337-B2 | Corrosion inhibition | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2021-04-20 | — | — | US | disclosed |
| US-20180312980-A1 | CORROSION INHIBITION | SCHLUMBERGER TECHNOLOGY CORPORATION | 2018-11-01 | — | — | US | disclosed |
| EP-3365477-A1 | CORROSION INHIBITION | Services Petroliers Schlumberger (FR) | 2018-08-29 | — | — | EP | disclosed |
| WO-2017070026-A1 | CORROSION INHIBITION | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2017-04-27 | — | — | WO | disclosed |
| WO-2017070026-A1 | CORROSION INHIBITION | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2017-04-27 | — | — | WO | disclosed |
| CN-106377150-A | Intelligent curtain control system based on technology of Internet of things and operation method thereof | 江苏建筑职业技术学院 | 2017-02-08 | — | — | CN | disclosed |
| US-8962624-B2 | Morpholines as selective inhibitors of cytochrome P450 2A13 | UNIVERSITY OF KANSAS (US) | 2015-02-24 | — | — | US | disclosed |
| US-8962624-B2 | Morpholines as selective inhibitors of cytochrome P450 2A13 | UNIVERSITY OF KANSAS (US) | 2015-02-24 | — | — | US | disclosed |
| US-8962624-B2 | Morpholines as selective inhibitors of cytochrome P450 2A13 | UNIVERSITY OF KANSAS (US) | 2015-02-24 | — | — | US | disclosed |
| US-20140045851-A1 | MORPHOLINES AS SELECTIVE INHIBITORS OF CYTOCHROME P450 2A13 | UNIVERSITY OF KANSAS (US) | 2014-02-13 | — | — | US | disclosed |
| US-20140045851-A1 | MORPHOLINES AS SELECTIVE INHIBITORS OF CYTOCHROME P450 2A13 | UNIVERSITY OF KANSAS (US) | 2014-02-13 | — | — | US | disclosed |
| US-20140045851-A1 | MORPHOLINES AS SELECTIVE INHIBITORS OF CYTOCHROME P450 2A13 | UNIVERSITY OF KANSAS (US) | 2014-02-13 | — | — | US | disclosed |
| US-8598165-B2 | Morpholines as selective inhibitors of cytochrome P450 2A13 | UNIVERSITY OF KANSAS (US) | 2013-12-03 | — | — | US | disclosed |
| US-20090137592-A1 | MORPHOLINES AS SELECTIVE INHIBITORS OF CYTOCHROME P450 2A13 | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-05-28 | — | — | US | disclosed |
| US-20090137592-A1 | MORPHOLINES AS SELECTIVE INHIBITORS OF CYTOCHROME P450 2A13 | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-05-28 | — | — | US | disclosed |
| US-20090137592-A1 | MORPHOLINES AS SELECTIVE INHIBITORS OF CYTOCHROME P450 2A13 | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137592-A1 | MORPHOLINES AS SELECTIVE INHIBITORS OF CYTOCHROME P450 2A13 | CYP1A2, CYP2D6, CYP1A1 | ALDH1A1 120/4885KDM4E 2221/4885KMT2A 1372/4885 |
| US-20180312980-A1 | CORROSION INHIBITION | AOC2, CA1, MAOB | ALDH1A1 622/4885KDM4E 3750/4885KMT2A 2894/4885 |
| US-10982337-B2 | Corrosion inhibition | AOC2, CA1, MAOB | ALDH1A1 622/4885KDM4E 3750/4885KMT2A 2894/4885 |
| US-20140045851-A1 | MORPHOLINES AS SELECTIVE INHIBITORS OF CYTOCHROME P450 2A13 | CYP1A2, CYP2D6, CYP1A1 | ALDH1A1 120/4885KDM4E 2221/4885KMT2A 1372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.